🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Post Stroke Dysphagia: Effect of Adding rTMS to Conventional Therapy on the Prevalence of Pneumonia.

RecruitingNAAges 49 Years - 65 YearsAllCairo University
NCT06123650 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

BACKGROUND: Dysphagia is one of the most life-threatening stroke complications. Dysphagic stroke patients are at increased risk of aspiration pneumonia. Pneumonia accounts for at least 10% of post stroke deaths within 30 days of hospitalization after stroke. rTMS is effective in improving post-stroke dysphagia and swallowing coordination after stimulation of the unaffected hemisphere, however it's efficacy on the prevalence of pneumonia has not yet been examined. Purpose of the study: To determine the effect of adding low frequency repetitive transcranial magnetic stimulation to conventional oropharyngeal physical therapy program on the prevalence of aspiration pneumonia in in patients with post stroke dysphagia.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. All the patients were diagnosed of stroke oropharyngeal dysphagia by a neurologist. Sever to moderate dysphagia (GUSS 0-14). 2. Severity of stroke ranged from mild to moderate according to NIHSS score (NIHSS less than or equal 16). 3. Patients' age ranged from 49 to 65 years old. 4. Patients had the ability to understand and follow instructions. 5. Patients were able to sit in upright position. Exclusion Criteria: 1. History of previous stroke. 2. History of any swallowing problem. 3. History of any head and neck surgery or tumor that causes swallowing dysfunction. 4. Any lung disease or pneumonia on admission. 5. Patients with cognitive deficits or disturbed conscious level. 6. Patients on mechanical ventilator. 7. Patients with sensory or global aphasia.
💊

What it tests

  • Repetitve transcranial magnetic stimulation
  • Sham transcranial magnetic stimulation
📍

Where

1 site
Faculty of Physical Therapy, Cairo University
Giza, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy